Description
A prodrug of the HIV-1 protease inhibitor amprenavir; improved solubility and pharmacokinetics compared with amprenavir and other HIV treatments
Formal name: N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-carbamic acid, (3S)-tetrahydro-3-furanyl ester, monocalcium salt
Synonyms: GW 433908G
Molecular weight: 623.7
CAS: 226700-81-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS